| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |